Research Site 40001-027 — Grants Pass, Oregon

Research Site 40001-027 is a clinical research site located in Grants Pass, Oregon, United States 97527.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Research Site 40001-027 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Eosinophilic Asthma, Asthma; Eosinophilic, Asthma Attack.

Sponsors: Areteia Therapeutics.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Grants Pass

Browse all research sites in Oregon · View every site in Grants Pass

• Three Rivers Community Hospital
• Velocity Clinical Research Grants Pass
• Research Site
• Velocity Clinical Research
• GSK Investigational Site
• Pfizer Investigational Site
• Teva Investigational Site 15646
• Kenji Hamada, OD
• Bausch Site 114
• Theravance Biopharma Investigational Site
• The Eye Care Group
• Orthopedic Center for Joint Replacement & Sports Medicine

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Research Site 40001-027?

Research Site 40001-027 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Research Site 40001-027 conducted?

Research Site 40001-027 has 1 clinical trials on record, with 1 currently active. Their work covers Eosinophilic Asthma, Asthma; Eosinophilic, Asthma Attack.

Is Research Site 40001-027 accredited by Crixeo Clinical Trials?

Research Site 40001-027 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Research Site 40001-027?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.